The novel dual GIP and GLP-1 receptor agonist, tirzepatide, transiently delays gastric emptying similarly to a selective long-acting GLP-1 receptor agonist

被引：0
|
作者：
Urva, S. [1 ]
Nauck, M. A. [2 ]
Coskun, T. [1 ]
Cui, X. [1 ]
Haupt, A. [1 ]
Benson, C. T. [1 ]
Loghin, C. [1 ]
机构：
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
[2] Diabet Ctr Bochum Hattingen, Bochum, Germany
来源：
DIABETOLOGIA | 2019年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
112
引用
收藏
页码：S58 / S58
页数：1
相关论文
共 50 条
  • [1] The Novel Dual GIP and GLP-1 Receptor Agonist Tirzepatide Transiently Delays Gastric Emptying Similarly to a Selective Long-Acting GLP-1 Receptor Agonist
    Urva, Shweta
    Nauck, Michael A.
    Coskun, Tamer
    Cui, Xuewei
    Haupt, Axel
    Benson, Charles
    Loghin, Corina
    [J]. DIABETES, 2019, 68
  • [2] Tirzepatide: A Novel Dual GIP and GLP-1 Receptor Agonist
    Wong, Elaine
    [J]. JNP- THE JOURNAL FOR NURSE PRACTITIONERS, 2023, 19 (01):
  • [3] Design of a novel long-acting dual GLP-1/GIP receptor agonist
    Dong, Yuanzhen
    Zhang, Jinhua
    Xu, Hongjiang
    Shen, Hengqiao
    Lu, Qin
    Feng, Jun
    Cai, Zhengyan
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2024, 100
  • [4] The novel GIP, GLP-1 and glucagon receptor agonist retatrutide delays gastric emptying
    Urva, Shweta
    O'Farrell, Libbey
    Du, Yu
    Loh, Mei Teng
    Hemmingway, Andrea
    Qu, Hongchang
    Alsina-Fernandez, Jorge
    Haupt, Axel
    Milicevic, Zvonko
    Coskun, Tamer
    [J]. DIABETES OBESITY & METABOLISM, 2023, 25 (09): : 2784 - 2788
  • [5] Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist
    Willard, Francis S.
    Douros, Jonathan D.
    Gabe, Maria
    Showalter, Aaron D.
    Wainscott, David B.
    Suter, Todd M.
    Capozzi, Megan E.
    van der Velden, Wijnand J. C.
    Stutsman, Cynthia
    Cardona, Guemalli R.
    Urva, Shweta
    Emmerson, Paul J.
    Holst, Jens J.
    D'Alessio, David A.
    Coghlan, Matthew P.
    Rosenkilde, Mette M.
    Campbell, Jonathan E.
    Sloop, Kyle W.
    [J]. JCI INSIGHT, 2020, 5 (17)
  • [6] The novel dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide transiently delays gastric emptying similarly to selectivelong-acting GLP-1 receptor agonists
    Urva, Shweta
    Coskun, Tamer
    Loghin, Corina
    Cui, Xuewei
    Beebe, Emily
    O'Farrell, Libbey
    Briere, Daniel A.
    Benson, Charles
    Nauck, Michael A.
    Haupt, Axel
    [J]. DIABETES OBESITY & METABOLISM, 2020, 22 (10): : 1886 - 1891
  • [7] Novel GLP-1 Fusion Chimera as Potent Long Acting GLP-1 Receptor Agonist
    Wang, Qinghua
    Chen, Kui
    Liu, Rui
    Zhao, Fang
    Gupta, Sandeep
    Zhang, Nina
    Prud'homme, Gerald J.
    [J]. PLOS ONE, 2010, 5 (09): : 1 - 9
  • [8] Effects of Renal Impairment on the Pharmacokinetics of the Dual GIP and GLP-1 Receptor Agonist Tirzepatide
    Urva, Shweta
    Quinlan, Tonya
    Landry, John
    Martin, Jennifer
    Loghin, Corina
    [J]. CLINICAL PHARMACOKINETICS, 2021, 60 (08) : 1049 - 1059
  • [9] Effects of Hepatic Impairment on the Pharmacokinetics of the Dual GIP and GLP-1 Receptor Agonist Tirzepatide
    Shweta Urva
    Tonya Quinlan
    John Landry
    Xiaosu Ma
    Jennifer A. Martin
    Charles T. Benson
    [J]. Clinical Pharmacokinetics, 2022, 61 : 1057 - 1067
  • [10] Effects of Hepatic Impairment on the Pharmacokinetics of the Dual GIP and GLP-1 Receptor Agonist Tirzepatide
    Urva, Shweta
    Quinlan, Tonya
    Landry, John
    Ma, Xiaosu
    Martin, Jennifer A.
    Benson, Charles T.
    [J]. CLINICAL PHARMACOKINETICS, 2022, 61 (07) : 1057 - 1067
12345